GERD (acid reflux) — all decisions

The Board remands the case to obtain an opinion regarding the severity of the Veteran's GERD with IBS without the ameliorative effects of medications.

The Board remands the claims for further development, including obtaining private medical records and updated TERA opinions.

The Board denied an earlier effective date for the grant of service connection for GERD, as October 3, 2023 is the correct effective date assigned.

The Board granted an increased 30 percent rating for tension migraine from February 6, 2024, to March 13, 2024, and a 50 percent rating for sleep apnea. It denied all other claims.

The Board granted service connection for peptic ulcer disease and pelvic congestion syndrome, and assigned initial ratings of 70%, 30%, 60%, 30%, 40%, and 10% for posttraumatic stress disorder (PTSD), gastroesophageal reflux disease (GERD), dermatitis, migraines, lumbosacral strain, and left lower extremity radiculopathy respectively. The Board remanded the claim of an initial rating in excess of 10 percent for costochondritis.

The Board granted an 80 percent rating for the Veteran's digestive disability and a 70 percent rating for his acquired psychiatric disorder, effective May 19, 2024.

The Board granted service connection for bilateral pes planus and denied the claims for a urinary disability, an earlier effective date for erectile dysfunction, and compensable ratings for pseudofolliculitis barbae, right ankle scars, and other conditions. The cervical spine and GERD with gastritis claims were remanded.

The appeals for service connection for fibromyalgia, narcolepsy, multiple sclerosis, constipation, thoracolumbar myofascial trigger points, GERD, and blurred vision and diplopia were dismissed. The appeal for hypertension was readjudicated based on new evidence.

The Board granted service connection for gastroesophageal reflux disease (GERD) as secondary to the Veteran's service-connected psychiatric disability, finding that the evidence was at least in equipoise.

The Board remands the case for a new medical opinion that addresses the Veteran's lay statements and provides an adequate medical opinion regarding the relationship between the Veteran's GERD and in-service symptoms.

The Board denied the veteran's claims for a higher rating and service connection for migraines, hypertension, diabetes mellitus type II, and a gastrointestinal disorder.

The Board denied service connection for asthma, GERD, sinusitis, and allergic rhinitis as there is no current disability related to these conditions. The claims for a back disorder and bilateral foot disorder were remanded for further development.

The Board remands the claims for service connection for GERD and a skin condition to correct duty to assist errors.

The Board remands the claim for service connection for acid reflux to ensure the Veteran is provided an adequate VA examination and medical opinion.

The Board denied service connection for anxiety, major depression, and gastroesophageal reflux disease (GERD) as the probative evidence did not show a current disability.

The Board granted service connection for a gastrointestinal disability, to include GERD, as secondary to medications taken for the Veteran's service-connected lumbar spine and bilateral knee disabilities.

The Board granted a 10 percent rating for GERD from October 15, 2024, and denied a compensable rating for hypertension. Sleep apnea was granted service connection.

The Board granted a 30 percent rating for gastroesophageal reflux disease (GERD) based on the Veteran's symptoms of dysphagia, pyrosis, reflux and or regurgitation, substernal pain, and sleep disturbances.

The Board denied an increased rating for the back disability and service connection for gallstones, GERD, IBS, and hiatal hernia as secondary to the service-connected back disability.

The Board granted service connection for generalized anxiety disorder with social anxiety, major depressive disorder, GERD, and bruxism based on their onset during the Veteran's active duty.